Navigation Links
Fertility Docs Cut Costs of IVF Conception by 60 Percent
Date:4/9/2009

IVF innovator introduces alternative to artificial insemination for less than $5,000

LAS VEGAS, April 9 /PRNewswire/ -- For decades women struggling to conceive a child usually have had but two stark choices for fertility treatments: the high-tech but high-cost process of in vitro fertilization (IVF), or the much lower-priced alternative of intra-uterine insemination (IUI), also known as artificial insemination - a clinical technique that fertility doctors generally consider a hit-and-miss proposition.

Now one of the nation's most visible innovators in fertility medicine - indeed, a pioneer in the development of IUI a quarter-century ago - is offering a third option: IVF priced competitively with artificial insemination.

This week the Sher Institutes for Reproductive Medicine (SIRM), a coast-to-coast network of private fertility clinics, began airing local TV and radio advertisements on for "Micro-IVF," a new offering that lowers the cost of in vitro treatment by more than 60 percent but is expected to triple the roughly 10-percent chance of pregnancy from a single IUI course.

The $4,950 price tag for a single Micro-IVF treatment contrasts sharply to the $13,000 to $15,000 national average that patients usually pay for a round of IVF (including medications). Yet with most fertility clinics charging from $3,000 to $4,000 for IUI, SIRM doctors believe they have the makings of a breakthrough offering.

"The truth is, IUI has often been an over-used process that's for years given false hope of success," said Dr. Geoffrey Sher, the founder of SIRM and, in 1984, the lead author of the first research paper on IUI ever published in the professional journal Fertility and Sterility.

"IUI is suitable only for a very limited group of women," Sher said. "In terms of success, in vitro fertilization is greatly superior to IUI, and now it's much more within the financial reach of the same population of infertile patients."

How can SIRM slash costs so dramatically? By targeting patients who otherwise are good candidates for IUI but deserve better odds - those who have the best chances of a successful outcome - and by avoiding expensive and time-intensive, high-tech processes and procedures needed for more difficult candidates.

"Many of these women might well get pregnant through IUI but in most cases, only after trying two, three, or four times or more," Sher said. "In the end, it is the cost per baby, not the cost per treatment, that must be considered, and a single Micro-IVF is three times more likely to succeed than one try at IUI."

Candidates for the program must meet certain conditions which would streamline their treatment, thus improving cost efficiencies: they must be under 36 years of age and have regular menstrual periods, and they must have no evidence of abnormally low reserves of eggs, no severe infertility in their male partners, and no health insurance coverage of IVF treatments.


'/>"/>
SOURCE Sher Institutes for Reproductive Medicine
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Infertility Issues and No Insurance Do Not Necessarily Mean No Hope for Baby
2. Male Infertility Treatment Boosts Sperm Count
3. Video: New First Response(R) Fertility Test Helps Women Answer the Question: Am I Able to Get Pregnant?
4. Some radiation therapy treatments can decrease fertility
5. Hormone Might Help Restore Female Fertility
6. Washington DC-area IVF Specialist Suheil Muasher, MD Addresses Fears of Infertility Treatments after Octuplet Mom News
7. Study sheds new light on link between obesity and infertility
8. New tool guides doctors to save cancer patients fertility
9. A Recession-Resistant Business? Introducing FertilityAuthority.com
10. Male infertility associated with testicular cancer
11. Male Infertility Tied to Testicular Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... attempts to compare student test score performance for the 2015-16 school year across ... state’s voucher programs. Though it highlights important patterns in student test score performance, ...
(Date:4/25/2017)... Las Vegas, NV (PRWEB) , ... April 25, ... ... teeth can now choose a modern procedure that achieves results in a fraction ... orthodontist in Las Vegas, NV, with Significance Dental Specialists, now offers this ...
(Date:4/25/2017)... ... , ... Back Pain Centers of America (BPC), which connects people ... their area, announces the launch of a new and proprietary customer relationship management (CRM) ... reputable physicians to help them with back or neck pain and helps to match ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... analytics to its patient care management module. Using this new feature, sleep physicians ... has been initiated on continuous positive airway pressure (CPAP), oral, or other forms ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
Breaking Medicine Technology: